Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats.
about
Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An updateClinical Advancements in the Targeted Therapies against Liver Fibrosis.Endogenous opiates and behavior: 2006Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liverMechanisms of hepatic fibrogenesisCurrent status of novel antifibrotic therapies in patients with chronic liver diseaseLoss of matrix metalloproteinase-2 amplifies murine toxin-induced liver fibrosis by upregulating collagen I expressionHepatic stellate cells and astrocytes: Stars of scar formation and tissue repair.micro-Opioid receptor activation prevents acute hepatic inflammation and cell death.Wound healing and local neuroendocrine regulation in the injured liver.Advances in antifibrotic therapy.Galactosylated LDL nanoparticles: a novel targeting delivery system to deliver antigen to macrophages and enhance antigen specific T cell responses.Cardiovascular abnormalities in obstructive cholestasis: the possible mechanisms.Opioid use and risk of liver fibrosis in HIV/hepatitis C virus-coinfected patients in Canada.Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy.Inhibition of nitric oxide synthesis during induced cholestasis ameliorates hepatocellular injury by facilitating S-nitrosothiol homeostasis.Effect of topical naltrexone 0.3% on corneal sensitivity and tear parameters in normal brachycephalic dogs.Nitric oxide mediates effects of acute, not chronic, naltrexone on LPS-induced hepatic encephalopathy in cirrhotic rats.Naltrexone changes the expression of lipid metabolism-related proteins in the endoplasmic reticulum stress induced hepatic steatosis in mice.A study on OPG/RANK/RANKL axis in osteoporotic bile duct-ligated rats and the involvement of nitrergic and opioidergic systems.
P2860
Q27027703-DD8C437A-43CB-4D63-B91E-84024C5A3F02Q28078684-3ED381EB-85F9-430C-BA48-C127420BD920Q28752585-1B792C58-79B8-4F4C-98D6-8161E21A6EDAQ29616840-DE260BAA-2427-4A4A-9F35-D6AB5D8625FEQ29619336-8B1799F2-D9FC-405A-A97D-CB92CECB00E8Q30473375-6B27F318-0426-4DF3-A78C-B6DDC73274F3Q34242444-8265D847-6155-4BEE-AD43-58D85AAB4CBBQ35124593-5BC7ADFD-C56F-40D9-A878-D84DC4128F1BQ36014007-9CF8DC06-3E20-41DD-9602-9902A95155D8Q37149500-D0BD9881-EEEA-49FA-8112-AC47A2013CE8Q37353099-8C17778B-C422-4593-B9C1-A2B4C406101FQ37436554-5ED20D2F-CA0A-4DF2-9C70-965967B43AFCQ38004171-0A8561B1-99AF-4BAD-918E-3A07A7C850C8Q40770942-4FD99DCC-751D-4B90-9D98-9273D92A1A3DQ42591676-8CC43B2B-5610-4185-9331-54654EFEA1F8Q43266690-4D1F07E3-5E97-4568-946D-6BCDDECB2EDEQ46773661-E629B649-E014-4496-BE07-5E5C9A45577BQ48374708-EE59E1B9-D323-4542-8216-94202EDD1CF2Q51076739-3F0D4AED-9978-4CDB-9A49-BF589EEC170DQ55090038-250851BB-92F9-4747-A2EB-4EE316227AA5
P2860
Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Naltrexone, an opioid receptor ...... sis in bile duct ligated rats.
@en
Naltrexone, an opioid receptor ...... sis in bile duct ligated rats.
@nl
type
label
Naltrexone, an opioid receptor ...... sis in bile duct ligated rats.
@en
Naltrexone, an opioid receptor ...... sis in bile duct ligated rats.
@nl
prefLabel
Naltrexone, an opioid receptor ...... sis in bile duct ligated rats.
@en
Naltrexone, an opioid receptor ...... sis in bile duct ligated rats.
@nl
P2093
P2860
P50
P356
P1433
P1476
Naltrexone, an opioid receptor ...... osis in bile duct ligated rats
@en
P2093
A Shariftabrizi
H Hoseininik
S Payabvash
P2860
P304
P356
10.1136/GUT.2005.076778
P407
P50
P577
2006-03-16T00:00:00Z